serotonin 5-HT1 receptor agonists

Preferred Label : serotonin 5-HT1 receptor agonists;

MeSH definition : Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.;

MeSH synonym : 5-HT1 agonist; 5 HT1 agonist; agonist, 5-HT1; 5-HT1 agonists; 5 HT1 agonists; agonists, 5-HT1; serotonin 5 HT1 receptor agonists;

MeSH hyponym : serotonin 5-HT1D receptor agonists; serotonin 5-HT1B receptor agonists; serotonin 5-HT1A receptor agonists; serotonin 5-HT1B-D agonists; Serotonin 5 HT1B Receptor Agonists; 5-HT1B Agonist; 5 HT1B Agonist; Agonist, 5-HT1B; Serotonin 5 HT1D Receptor Agonists; 5-HT1D Agonist; 5 HT1D Agonist; Agonist, 5-HT1D; Serotonin 5 HT1A Receptor Agonists; 5-HT1A Agonist; 5 HT1A Agonist; Agonist, 5-HT1A; 5-HT1B-D Agonists, Serotonin; Agonists, Serotonin 5-HT1B-D; Serotonin 5 HT1B D Agonists; 5-HT1B-D Agonist; 5 HT1B D Agonist; Agonist, 5-HT1B-D;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058825;

UMLS CUI

C0162754;

ATC code(s)
- selective serotonin (5ht1) agonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Product containing serotonin 5-hydroxytryptamine-1 receptor agonist (product) [SNOMED CT concept]
- Serotonin 5-hydroxytryptamine-1 receptor agonist (disposition) [SNOMED CT concept]
CISMeF manual mappings
- Substance with serotonin 5-hydroxytryptamine-1 receptor agonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 2-(4-((2-(2-ethoxyphenoxy)ethyl)amino)butyl)tetrahydro-1H-pyrrolo(1,2-c)imidazole-1,3(2H)-dione [MeSH Supplementary Concept]
- 2-(6-((3,4-dihydro-2H-chromen-2-ylmethyl)amino)hexyl)tetrahydro-1H-pyrrolo(1,2-c)imidazole-1,3(2H)-dione [MeSH Supplementary Concept]
- N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- Receptor, Serotonin, 5-HT1F [MeSH Descriptor]
- receptor, serotonin, 5-ht1a [MeSH Descriptor]
- receptor, serotonin, 5-ht1b [MeSH Descriptor]
- receptor, serotonin, 5-ht1d [MeSH Descriptor]
- receptors, serotonin, 5-ht1 [MeSH Descriptor]
Record concept(s)
- serotonin 5-HT1 receptor agonists [MeSH concept]
- serotonin 5-HT1A receptor agonists [MeSH concept]
- serotonin 5-HT1B receptor agonists [MeSH concept]
- serotonin 5-HT1B-D agonists [MeSH concept]
- serotonin 5-HT1D receptor agonists [MeSH concept]
See also (suggested by CISMeF)
- rizatriptan [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 11-allyloxy-N-methylaporphine [MeSH Supplementary Concept]
- 11-propargyloxy-N-methylaporphine [MeSH Supplementary Concept]
- 2-((4-(naphth-1-yl)piperazin-1-yl)methyl)-1,4-dioxoperhydropyrrolo(1,2-a)pyrazine [MeSH Supplementary Concept]
- 2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione [MeSH Supplementary Concept]
- 2-(4-(4-(7-methoxynaphthalen-1-yl)piperazin-1-yl)butyl)-4-methyl-2H-(1,2,4)triazine-3,5-dione [MeSH Supplementary Concept]
- 3-amino-5,6,7,8-tetrahydro-2-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)quinazolin-4-(3H)-one [MeSH Supplementary Concept]
- 3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methylpyrimidin-2-ylmethyl)amino)methyl)piperidin-1-yl)methanone [MeSH Supplementary Concept]
- 6-methyl-2-(4-(naphthylpiperazin-1-yl)butyl)-3-(2H)-pyridazinone [MeSH Supplementary Concept]
- 8-((3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-hydroxypropyl)oxy)thiochroman [MeSH Supplementary Concept]
- Aripiprazole [MeSH Descriptor]
- N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine [MeSH Supplementary Concept]
- N-methyl-2'-methyl-2',3'-dihydrofuro(m)aporphine [MeSH Supplementary Concept]
- PNU 142093 [MeSH Supplementary Concept]
- Piclozotan [MeSH Supplementary Concept]
- Vilazodone Hydrochloride [MeSH Descriptor]
- Vortioxetine [MeSH Descriptor]
- befiradol [MeSH Supplementary Concept]
- cyclohexanecarboxylic acid (2-(4-(2-bromo-5-methoxybenzyl)piperazin-1-yl)ethyl)-(2-trifluoromethoxyphenyl)amide [MeSH Supplementary Concept]
- cyclohexanecarboxylic acid, (2-methoxyphenyl)-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)amide [MeSH Supplementary Concept]
- naluzotan [MeSH Supplementary Concept]
- naratriptan [MeSH Supplementary Concept]
- repinotan hydrochloride [MeSH Supplementary Concept]
- sumatriptan [MeSH Descriptor]
- xaliproden [MeSH Supplementary Concept]
- zolmitriptan [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing serotonin 5-hydroxytryptamine-1 receptor agonist (product) [SNOMED CT concept]
- Substance with serotonin 5-hydroxytryptamine-1 receptor agonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients